News | Page 15 | Weill Department of Medicine

Dr. Brandman Appointed as Medical Director for the Center for Liver Disease and Transplantation

Dr. Danielle BrandmanDanielle Brandman, M.D., M.A.S., has been appointed as the Medical Director for liver transplantation at Weill Cornell’s Center for Liver Disease and Transplantation (CLDT). The Center is run by Weill Cornell Medicine in partnership with NewYork-Presbyterian.Dr. Brandman was recruited to Weill Cornell from the University of California-San Francisco (UCSF) by Dr. Robert Brown to serve in this role following his promotion to Chief of Gastroenterology and Hepatology in the... Read More

WDOM Celebrates Dr. Johnson’s 60 Years of Distinguished Service in Infectious Diseases and Global Health

Dr. Warren D. Johnson, Jr.Former Division Chief of Infectious Diseases and founding Director of the Center for Global Health, Dr. Warren D. Johnson, Jr., is being celebrated on December 13, 2022, in honor of his 60 years of distinguished service as a physician, investigator, scholar, educator, and pioneer on the world stage.Dr. Johnson’s many years of leadership are legendary. He has mentored faculty and investigators working on some of the most virulent infectious diseases that exist around... Read More

In Recognition of National COPD Awareness Month the WDOM Highlights Dr. Martinez and the Division of Pulmonary and Critical Care Medicine

As November is National COPD Awareness Month, the WDOM recognizes the seminal work of Dr. Martinez and the faculty of the Division of Pulmonary and Critical Care Medicine.The National Institutes of Health notes that National COPD Awareness Month is a time to unite the COPD (chronic obstructive pulmonary disease) community in an effort to help patients, family caregivers and healthcare providers in order to find better treatments and/or a cure for COPD. COPD is the third leading cause of death... Read More

Dr. Prigerson Wins $7 Million Outstanding Investigator Award from the National Cancer Institute

Dr. Holly PrigersonFeatured in CRAIN's New York Business, Dr. Holly Prigerson has received a $7 Million Outstanding Investigator Award from the National Cancer Institute that will further her study of the psychosocial influences on care for dying cancer patients.A seven year renewal grant, this award will further research that Dr. Prigerson has been working on since 2015 focused on aggressive end-of-life care. In particular, Dr. Prigerson and her team will be piloting several interventions... Read More

Advancing Women’s Health: Key Updates on Screening and Treatment

Dr. Alexandra KingDr. Alexandra King, Assistant Professor of Medicine in the Division of General Internal Medicine, recently shared revised innovative screening guidelines for women’s health, including cervical cancer, breast cancer, bacterial vaginosis (BV) and menopause, incorporating the latest research and updates from the U.S. Preventive Services Task Force (USPSTF) to improve care for women at every stage of life.Cervical CancerFor cervical cancer, Dr. King stated that women aged 21-30... Read More

Annual Weill Department of Medicine Awards Recognize Exceptional Achievements

The Weill Department of Medicine held its annual Medicine Grand Rounds awards in June.The Young Fellows Awards was founded by Dr. Ralph L. Nachman to encourage fellows in the Weill Department of Medicine to continue creative investigative research in internal medicine. The award recognizes outstanding scholarship. Congratulations to our 2025 awardees, first place winner Dr. John-William Sidhom, first runner up, Dr. Herman van Besien and second runner up Dr. Lasha Gogokhia. The 31st Young... Read More

Immune Tolerance to Gut Microbes Is Initiated by a Key Bacterial Sensor

Thousands of bacterial and other microbial species live in the human gut, supporting healthy digestion, immunity, metabolism and other functions. Precisely how these microbes are protected from immune attack has been unclear, but now a study led by Weill Cornell Medicine investigators has found that this immune “tolerance” to gut microbes depends on an ancient bacterial-sensing protein called STING—normally considered a trigger for inflammation. The surprising result could lead to new... Read More

Diversity Week Presentation Highlights Cornell Center for Health Equity and Diversity Center of Excellence

Although only 5% of active physicians are African American and 5.8% are Latino (2019 AAMC Diversity in Medicine report), Weill Cornell Medicine is dedicating time, energy and empathy to build inclusive environments. In recognition of Weill Cornell Medicine’s recent Diversity Week, the Weill Department of Medicine’s Grand Rounds on April 9, 2025 focused on the extraordinary work of the Cornell Center for Health Equity (CCHEq) and the Diversity Center of Excellence (DCOE), both partially based in... Read More

Gut Microbes Release Cancer-fighting Bile Acids that Block Hormone Signals

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators. The study was published on April 15 in Cell.Dr. Chun-Jun Guo. Credit: Ashley Jones“I was very surprised by our findings. As far as I know, no one has previously discovered molecules like these bile... Read More

Quality & Patient Safety: A Conversation with Dean Robert Harrington and Dr. Robert Min

In recognition of Patient Safety Awareness Week, the Weill Department of Medicine's Quality & Patient Safety team helped coordinate a fireside-style chat with Dean Robert Harrington and Dr. Robert Min for faculty, staff and students titled "Igniting the Future of Quality and Patient Safety" in Uris on March 13.The discussion highlighted the importance of creating an environment that allows for questions and collaboration. Both Dean Harrington and Dr. Min shared past experiences that led... Read More